Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about DNMT1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
DNMT1 is a protein involved in neurodegeneration research. Key relationships include: associated with, activates, expressed in. Associated with ALS, Aging, Als. Connected to 156 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | DNMT1 |
| Chromosome | 19p13.2<br> |
| Protein Type | Epigenetic Regulator |
| Target Class | Epigenetic Regulator |
| Function | DNMT1 maintains DNA methylation patterns by copying methylation from the parental DNA strand to the newly synthesized strand. |
| Mechanism of Action | Small molecule inhibitor of DNA methyltransferase activity |
| Primary Expression | all tissues with high expression in: - Developing brain (neurons and progenitors) - Adult hippocampus (CA1, dentate gyrus) - Cere |
| Druggability | Medium (0.52) |
| Clinical Stage | Approved |
| Molecular Weight | 183 kDa |
| Pathways | Differentiation, Epigenetic, Immune Response |
| UniProt ID | P26358 |
| NCBI Gene ID | 1785 |
| Ensembl ID | ENSG00000123091 |
| GeneCards | DNMT1 |
| Human Protein Atlas | DNMT1 |
| Associated Diseases | Als, Alzheimer's disease, Amyotrophic Lateral Sclerosis, Ataxia |
| Known Drugs/Compounds | rapamycin, RAPAMYCIN |
| Interactions | AKT, amyotrophic lateral sclerosis, AND, APOPTOSIS, AUTOPHAGY, BAX |
| SciDEX Target | View Target Profile (8 clinical trials) |
| SciDEX Hypotheses | DNMT1-Targeting Antisense Oligonucleotide Reset DNMT1 Compensation Window During Synaptic Resilien DNMT1 Downregulation to Correct Genome-Wide Hypome |
| KG Connections | 443 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
DNMT1["DNMT1"]
DNMT1 -->|"inhibits"| BMAL1["BMAL1"]
DNMT1 -->|"regulates"| Ms["Ms"]
DNMT1 -->|"activates"| Carcinoma["Carcinoma"]
DNMT1 -->|"expressed in"| Cancer["Cancer"]
DNMT1 -->|"interacts"| Als["Als"]
DNMT1 -->|"interacts"| Schizophrenia["Schizophrenia"]
DNMT1 -->|"target for"| Aging["Aging"]
DNMT1 -->|"regulates"| GENES["GENES"]
h_782e55f6["h-782e55f6"] -->|"target for"| DNMT1
h_74777459["h-74777459"] -->|"target for"| DNMT1
RB1["RB1"] -->|"regulates"| DNMT1
IL17A["IL17A"] -->|"activates"| DNMT1
MAPK["MAPK"] -->|"activates"| DNMT1
PDPK1["PDPK1"] -->|"regulates"| DNMT1
CANCER["CANCER"] -->|"expressed in"| DNMT1
RELN["RELN"] -->|"interacts"| DNMT1| Target | Relation | Type | Str |
|---|---|---|---|
| BMAL1 | inhibits | gene | 0.90 |
| CHKA | downregulates | gene | 0.90 |
| CHKB | downregulates | gene | 0.90 |
| epigenetic regulation | participates_in | pathway | 0.85 |
| Cancer Stem Cells | associated_with | cell_type | 0.80 |
| Triple-Negative Breast Cancer | associated_with | disease | 0.80 |
| Estrogen Receptor | associated_with | protein | 0.80 |
| CpG_methylation | methylates | epigenetic_mark | 0.80 |
| Carcinoma | activates | disease | 0.75 |
| Cancer | expressed_in | disease | 0.75 |
| Cancer | activates | disease | 0.75 |
| DNMT3A | stabilizes | gene | 0.70 |
| Autophagy | activates | pathway | 0.70 |
| BMAL1 | regulates | gene | 0.70 |
| AKT | activates | gene | 0.70 |
| GENES | regulates | gene | 0.70 |
| Epithelial-Mesenchymal Transition | activates | pathway | 0.70 |
| neural stem cells | activates | cell_type | 0.70 |
| EZH2 | regulates | gene | 0.70 |
| CANCER | activates | gene | 0.70 |
| UBIQUITIN | modifies | protein | 0.70 |
| SYNAPTIC PLASTICITY | protects_against | phenotype | 0.70 |
| ALZHEIMER'S DISEASE | causes | disease | 0.70 |
| NEURODEGENERATION | treats | phenotype | 0.70 |
| NEURODEGENERATION | inhibits | phenotype | 0.70 |
| NEURON | causes | cell_type | 0.70 |
| Atherosclerosis | activates | disease | 0.65 |
| Als | interacts_with | disease | 0.65 |
| Ferroptosis | activates | disease | 0.65 |
| Liver Cancer | expressed_in | disease | 0.65 |
| Carcinoma | causes | disease | 0.65 |
| Schizophrenia | interacts_with | disease | 0.65 |
| Tumor | activates | disease | 0.65 |
| TET2 | inhibits | gene | 0.65 |
| DNMT3A | associated_with | gene | 0.65 |
| Breast Cancer | therapeutic_target | disease | 0.65 |
| neurodegeneration | regulates | disease | 0.65 |
| Carcinoma | expressed_in | disease | 0.65 |
| Cancer | therapeutic_target | disease | 0.65 |
| Spinal Muscular Atrophy | associated_with | disease | 0.65 |
| Inflammation | expressed_in | disease | 0.65 |
| Tumor | inhibits | disease | 0.65 |
| Neuroinflammation | expressed_in | disease | 0.65 |
| Frontotemporal Dementia | associated_with | disease | 0.65 |
| Ftd | associated_with | disease | 0.65 |
| DNMT3A | regulates | gene | 0.65 |
| Autism | expressed_in | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| Cancer | associated_with | disease | 0.65 |
| Spinocerebellar Ataxia | associated_with | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| h-74777459 | targets | hypothesis | 0.90 |
| h-782e55f6 | targets | hypothesis | 0.90 |
| Thermal adaptation | upregulates | process | 0.85 |
| Arsenic | upregulates | compound | 0.85 |
| NFKB | associated_with | gene | 0.80 |
| RB1 | regulates | gene | 0.80 |
| NEURONS | treats | cell_type | 0.70 |
| MAPK | activates | pathway | 0.70 |
| IL17A | activates | protein | 0.70 |
| PDPK1 | regulates | gene | 0.70 |
| LC3 | associated_with | gene | 0.60 |
| BECN1 | associated_with | gene | 0.60 |
| HTT | associated_with | gene | 0.60 |
| SETX | associated_with | gene | 0.60 |
| SQSTM1 | associated_with | gene | 0.60 |
| ALS4 | associated_with | gene | 0.60 |
| SMN1 | associated_with | gene | 0.60 |
| ATG7 | associated_with | gene | 0.60 |
| ACTB | associated_with | gene | 0.60 |
| GABARAP | associated_with | gene | 0.60 |
| ULK1 | associated_with | gene | 0.60 |
| WIPI2 | associated_with | gene | 0.60 |
| ACTB | regulates | gene | 0.60 |
| ATG7 | regulates | gene | 0.60 |
| BECN1 | regulates | gene | 0.60 |
| CANCER | expressed_in | gene | 0.60 |
| DNA | associated_with | gene | 0.60 |
| MTORC1 | associated_with | gene | 0.60 |
| NEURODEGENERATIVE DISORDERS | regulates | gene | 0.60 |
| NEURON | associated_with | gene | 0.60 |
| ALS | associated_with | gene | 0.60 |
| MAP1LC3 | associated_with | gene | 0.60 |
| AUTOPHAGY | associated_with | gene | 0.60 |
| RNA | expressed_in | gene | 0.60 |
| CD8 | activates | gene | 0.60 |
| DNA | activates | gene | 0.60 |
| GENES | activates | gene | 0.60 |
| ACTB | activates | entity | 0.60 |
| ALS4 | activates | entity | 0.60 |
| ATG7 | activates | entity | 0.60 |
| BECN1 | activates | entity | 0.60 |
| AND | activates | gene | 0.60 |
| P53 | activates | gene | 0.60 |
| APOPTOSIS | activates | gene | 0.60 |
| AUTOPHAGY | activates | gene | 0.60 |
| ERK | activates | gene | 0.60 |
| rapamycin | targets | drug | 0.60 |
| ADRA2A | expressed_in | gene | 0.60 |
| DNMT3B | expressed_in | gene | 0.60 |
| DNA | regulates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| DNMT1-Targeting Antisense Oligonucleotide Reset | 0.648 | neurodegeneration | Epigenetic clocks and biological aging i |
| DNMT1 Compensation Window During Synaptic Resilience Phase | 0.528 | neurodegeneration | What is the optimal therapeutic window d |
| DNMT1 Downregulation to Correct Genome-Wide Hypomethylation | 0.380 | neurodegeneration | Comparative epigenetic signatures across |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-16 | 7 hypotheses Top: 0.550
neurodegeneration | 2026-04-03 | 45 hypotheses Top: 0.990
neurodegeneration | 2026-04-01 | 6 hypotheses Top: 0.710
neurodegeneration | 2026-04-01 | 13 hypotheses Top: 0.888
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Assessment of Out-of-Pocket Costs for Robotic Cancer Surgery in US Adults. [PMID:31940036] | Nabi J, Friedlander DF, Chen X, Cole AP, | JAMA Netw Open | 2020 | 1 |
| Multidisciplinary Approach to Interstitial Lung Diseases: Nothing Is Better than [PMID:32709146] | Vancheri C, Basile A | Diagnostics (Basel) | 2020 | 1 |
| Higher-Order Inter-chromosomal Hubs Shape 3D Genome Organization in the Nucleus. [PMID:29887377] | Quinodoz SA, Ollikainen N, Tabak B, Pall | Cell | 2018 | 1 |
| Combinatorial CRISPR-Cas9 screens for de novo mapping of genetic interactions. [PMID:28319113] | Shen JP, Zhao D, Sasik R, Luebeck J, Bir | Nat Methods | 2017 | 1 |
| The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation [PMID:20644199] | McKenna A, Hanna M, Banks E, Sivachenko | Genome Res | 2010 | 1 |
| Prevalence of clinical and radiographic signs of osteoarthrosis of the temporoma [PMID:20395464] | Schmitter M, Essig M, Seneadza V, Balke | Dentomaxillofac Radiol | 2010 | 1 |
| Disrupting the epigenetic alliance: structural insights and therapeutic strategi [PMID:40960568] | Kamel EM, Ali MAM, Allam AA, Ahmed NA, A | Functional & integrative genom | 2025 | 0 |
| Flow cytometry of DNMT1 as a biomarker of hypomethylating therapies. [PMID:38345160] | Woost PG, William BM, Cooper BW, Ueda Os | Cytometry. Part B, Clinical cy | 2024 | 0 |
| DNMT1-targeting remodeling global DNA hypomethylation for enhanced tumor suppres [PMID:38755637] | Liu Y, Sun Y, Yang J, Wu D, Yu S, Liu J, | Molecular cancer | 2024 | 0 |
| Bi-functional CpG-STAT3 decoy oligonucleotide triggers multilineage differentiat [PMID:39171140] | Wang D, Kaniowski D, Jacek K, Su YL, Yu | Molecular therapy. Nucleic aci | 2024 | 0 |
| A precise and efficient circular RNA synthesis system based on a ribozyme derive [PMID:37378451] | Cui J, Zhang L, Zhang Z, Luo X, Liu Y, L | Nucleic acids research | 2023 | 0 |
| Channel branching and zigzagging in negative cloud-to-ground lightning. [PMID:28615706] | ["Jiang R", "Qie X", "Zhang H", "Liu M", | Scientific reports | 2017 | 0 |
| Sequential transcriptional waves direct the differentiation of newborn neurons i [PMID:26940868] | ["Telley L", "Govindan S", "Prados J", " | Science (New York, N.Y.) | 2016 | 0 |
| Incorporating theology into medical education. [PMID:23209119] | Adam Miller | CMAJ : Canadian Medical Associ | 2013 | 0 |
Multi-agent debates referencing this entity
closed · Rounds: 4 · Score: 0.50 · 2026-04-18
closed · Rounds: 4 · Score: 0.93 · 2026-04-06
closed · Rounds: 4 · Score: 0.95 · 2026-04-03
closed · Rounds: 4 · Score: 0.95 · 2026-04-01
Hypotheses and analyses mentioning DNMT1 in their description or question text
No additional research found